天图魏国兴：卓正团队始终坚守医疗本质，持续关注医疗健康领域的投资机遇

Core Viewpoint - TianTu Investment's third healthcare fund is currently in fundraising, highlighting the firm's ongoing commitment to the healthcare sector and its strategic investments in high-potential companies like Zhuozheng Medical [2][5]. Group 1: Company Overview - Zhuozheng Medical Holdings Limited is set to be listed on the Hong Kong Stock Exchange on February 6, 2026, under the stock code "2677" [3]. - It is recognized as the private mid-to-high-end comprehensive medical service institution group with the widest coverage in Chinese cities, having attracted investments from notable firms including TianTu Investment and others [3]. Group 2: Investment Strategy - TianTu Investment led Zhuozheng Medical's C round financing in 2017 and has been a key institutional investor, providing ongoing support in strategic areas such as brand positioning and resource integration [4]. - The firm has identified the growing demand for high-quality medical services driven by rising living standards, positioning mid-to-high-end private medical services as a long-term investment opportunity [5]. Group 3: Business Model and Growth Potential - Zhuozheng Medical has developed a comprehensive service model that includes multiple specialties, focusing on a family doctor-centered membership plan to enhance user engagement and service frequency [4]. - The company is expected to benefit from trends such as refined parenting, aging population, and increasing family healthcare needs, which will expand the medical service market and accelerate its growth [5]. Group 4: Broader Investment Landscape - Beyond healthcare services, TianTu Investment is also exploring opportunities in innovative pharmaceuticals and synthetic biology, supported by two healthcare-themed funds that have facilitated the rapid growth of several high-potential companies [5]. - The firm has established a multi-strategy investment matrix centered on "consumption + technology," aiming to support companies' stable development and value enhancement through long-term capital and professional post-investment empowerment [5].